Michael Georgieff
Papers
1
Total Citations
4
H-Index
1
About
Michael Georgieff’s research career is defined by pioneering work in the automation of radioligand binding assays, a cornerstone technique in clinical and pharmaceutical research. His most notable contribution, detailed in his 1993 paper “A Partially Automated Radioligand Binding Assay System for use in Clinical and Pharmaceutical Research,” introduced a flexible system that integrated a Tecan robotic sample processor with IBM-compatible PCs. This innovation allowed for the simultaneous handling of up to 16 saturation or competition experiments, each with up to 24 radioligand or competitor concentrations—a significant leap in throughput and reproducibility for its time. While his citation count for this work stands at 4, its impact lies in its foundational role in advancing assay automation, influencing subsequent developments in high-throughput screening and drug discovery. Georgieff’s achievement reflects a deep understanding of both laboratory robotics and computational control, bridging manual techniques with modern automation. His work remains a reference point for researchers seeking to optimize binding studies, demonstrating how targeted technical innovations can streamline complex experimental workflows in pharmacology and clinical diagnostics.
Research Focus
Key Achievements
Top Papers
- 1